Live feed07:00:00·1642dPRReleasevia QuantisnowEyeGate Pharmaceuticals Appoints Eric J. Daniels, MD, MBA, as Chief Development Officer and Closes Acquisition of Bayon Therapeutics, Inc.ByQuantisnow·Wall Street's wire, on your screen.EYEG· Eyegate Pharmaceuticals, Inc.Health Care
